Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

Clinical trial NCT01134055 · COMPLETED

Trial details

NCT number: NCT01134055
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2010-06-01
Primary completion: 2012-10-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.